Precise Co-Delivery Mechanism:

The FMD ingeniously combines fiberoptic technology with microneedles to co-deliver targeted light and gold nanoparticles, enhancing the effectiveness of Plasmonic Photothermal Therapy.

Optimized Treatment Parameters

Through a comprehensive study, the device allows for precise control over treatment parameters, including laser wavelengths, irradiances, and gold nanorod concentrations, ensuring a tailored and effective therapeutic response.

Enhanced Selectivity and Efficiency

Results indicate a remarkable 200% higher temperature rise when utilizing gold nanoparticles and an 808 nm wavelength, showcasing the FMD’s ability to achieve superior hyperthermic generation and spatially selective treatment for pancreatic cancer.

Fiber Optic Microneedle Device

Safe alternative drug administration procedure for carcinoma

Introducing the Fiberoptic Microneedle Device (FMD), a cutting-edge solution at the forefront of cancer treatment innovation. This device is designed to revolutionize Plasmonic Photothermal Therapy (PPTT), offering a superior approach to combat pancreatic cancer – a disease characterized by limited treatment options. This pioneering Fiberoptic Microneedle Device not only promises an advanced treatment modality but also introduces a potential breakthrough in the fight against pancreatic cancer, addressing the need for more selective and efficient therapeutic options.